Suppliers / PolarisAIPharmaCorp

PolarisAIPharmaCorp

Japan Updated 9 July 2026

PolarisAIPharmaCorp is an API manufacturer based in Japan.

0
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Apixaban PMDA (Japan) 1
Aripiprazole PMDA (Japan) 1
Entecavir PMDA (Japan) 1
Glimepiride PMDA (Japan) 1
オルメサルタンメドキソミル PMDA (Japan) 1
ピオグリタゾン塩酸塩 PMDA (Japan) 1
ピタバスタチンカルシウム PMDA (Japan) 1
フルボキサミンマレイン酸塩 PMDA (Japan) 1
プランルカスト水和物(製造専用) PMDA (Japan) 1
モンテルカストナトリウム PMDA (Japan) 1
Show all 15 molecules on file
レバミピド(製造専用) PMDA (Japan) 1
ロキサチジン酢酸エステル塩酸塩 PMDA (Japan) 1
Droxidopa PMDA (Japan) 1
Duloxetinehydrochloride PMDA (Japan) 1
Ebastine PMDA (Japan) 1

Also appears on these molecule pages

Comparing suppliers?

Choose your molecules and target markets. PolarisAIPharmaCorp comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability